Drug Type Chemical drugs |
Synonyms M480 |
Target |
Action agonists |
Mechanism FXR agonists(Bile acid receptor FXR agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammatory Bowel Diseases | Preclinical | United States | 01 Jun 2018 | |
Nonalcoholic Steatohepatitis | Preclinical | United States | 01 Jun 2018 |